Trial intelligence / Profile preview

Propofol versus placebo for acute migraine in the emergency department

ACTRN12615000910505Phase 4Recruiting

Sponsor
Dandenong Hospital
Start
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in migraine comparing Propofol with Placebo (Intralipid 20%) (2 arms). Primary endpoint: Headache resolution by 1 hour. Started Feb 2016; status: recruiting.

02

Drugs

propofol
03

Conditions

migraine

Beyond the preview

Go deeper on ACTRN12615000910505.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12615000910505.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call